These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2152 related articles for article (PubMed ID: 32767571)
1. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews. Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571 [TBL] [Abstract][Full Text] [Related]
2. Inhaled magnesium sulfate in the treatment of acute asthma. Knightly R; Milan SJ; Hughes R; Knopp-Sihota JA; Rowe BH; Normansell R; Powell C Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003898. PubMed ID: 29182799 [TBL] [Abstract][Full Text] [Related]
3. Interventions for managing asthma in pregnancy. Bain E; Pierides KL; Clifton VL; Hodyl NA; Stark MJ; Crowther CA; Middleton P Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010660. PubMed ID: 25331331 [TBL] [Abstract][Full Text] [Related]
4. Inhaled magnesium sulfate in the treatment of acute asthma. Powell C; Dwan K; Milan SJ; Beasley R; Hughes R; Knopp-Sihota JA; Rowe BH Cochrane Database Syst Rev; 2012 Dec; 12():CD003898. PubMed ID: 23235599 [TBL] [Abstract][Full Text] [Related]
5. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Griffiths B; Ducharme FM Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133 [TBL] [Abstract][Full Text] [Related]
6. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department. Kew KM; Kirtchuk L; Michell CI Cochrane Database Syst Rev; 2014 May; 2014(5):CD010909. PubMed ID: 24865567 [TBL] [Abstract][Full Text] [Related]
7. Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital. Vézina K; Chauhan BF; Ducharme FM Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010283. PubMed ID: 25080126 [TBL] [Abstract][Full Text] [Related]
8. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma. Travers AH; Jones AP; Camargo CA; Milan SJ; Rowe BH Cochrane Database Syst Rev; 2012 Dec; 12():CD010256. PubMed ID: 23235686 [TBL] [Abstract][Full Text] [Related]
9. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639 [TBL] [Abstract][Full Text] [Related]
10. Interventions for bronchiectasis: an overview of Cochrane systematic reviews. Welsh EJ; Evans DJ; Fowler SJ; Spencer S Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010337. PubMed ID: 26171905 [TBL] [Abstract][Full Text] [Related]
11. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease. Ni H; Aye SZ; Naing C Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126 [TBL] [Abstract][Full Text] [Related]
12. Antibiotics for exacerbations of asthma. Normansell R; Sayer B; Waterson S; Dennett EJ; Del Forno M; Dunleavy A Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002741. PubMed ID: 29938789 [TBL] [Abstract][Full Text] [Related]
13. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. Kew KM; Dahri K Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011721. PubMed ID: 26798035 [TBL] [Abstract][Full Text] [Related]
14. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959 [TBL] [Abstract][Full Text] [Related]
15. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma. Chauhan BF; Ducharme FM Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050 [TBL] [Abstract][Full Text] [Related]
16. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. O'Shea O; Stovold E; Cates CJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162 [TBL] [Abstract][Full Text] [Related]
17. Combined inhaled beta-agonist and anticholinergic agents for emergency management in adults with asthma. Kirkland SW; Vandenberghe C; Voaklander B; Nikel T; Campbell S; Rowe BH Cochrane Database Syst Rev; 2017 Jan; 1(1):CD001284. PubMed ID: 28076656 [TBL] [Abstract][Full Text] [Related]
18. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cates CJ; Karner C Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340 [TBL] [Abstract][Full Text] [Related]
19. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthma. Gallagher A; Edwards M; Nair P; Drew S; Vyas A; Sharma R; Marsden PA; Wang R; Evans DJ Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012929. PubMed ID: 34664263 [TBL] [Abstract][Full Text] [Related]
20. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma. Kew KM; Evans DJ; Allison DE; Boyter AC Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011438. PubMed ID: 26031392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]